Precision Motion Health has developed an FDA-registered, class-II diagnostic device called an Electrodiagnostic Functional Assessment (EFA) that can age and evaluate muscle activity, distinguish between acute versus chronic injury, and objectively quantify effort.
The EFA-Soft Tissue Management (STM) Program is a patent-pending process that has been specifically designed for an employer’s current workforce, as well as new hires, in compliance with ADA and EEOC regulations. It begins with a baseline assessment, which is not read, but instead is stored in a secured database. When a work-related injury is reported, a post-injury assessment is performed, at which time the information collected from the baseline assessment is compared to the data from the post-injury assessment. The baseline data is read only if an injury occurs and the post-loss assessment is performed.
The EFA-STM Program allows employers to establish pre-injury status and provides the objective data necessary to accurately diagnose soft-tissue injuries which ultimately leads to better treatment outcomes for employees and patients.
Please sign up for our mailing list to periodically receive exciting invitations and information from Emerge Diagnostics: http://eepurl.com/bCKCk5
Industry
Technology, Information and Internet, Health and Human Services
HQ Location
5840 El Camino Real
102
Carlsbad, California 92008, US
Keywords
Electrodiagnostic Functional Assessment (EFA)Soft Tissue Management (STM)Diagnostic Provider ServicesWorkers' Compensation / Risk Management